|
Advice/action
|
Observations 1
|
Occurrences 2
|
Sensitivity
|
Specificity
|
|---|
| |
N
|
N
|
% (95% CI)
|
% (95% CI)
|
|---|
|
Advice:
| | | | |
|
Dosage regimen
|
1229
|
1027
|
96.4 (93.6, 98.0)
|
53.5 (40.2, 66.2)
|
|
Dietary
|
1251
|
81
|
54.4 (41.9, 66.2)
|
94.1 (92.0, 95.6)
|
|
Adverse effects
|
1253
|
36
|
36.2 (16.8, 61.2)
|
98.6 (97.6, 99.2)
|
|
Re-engagement
|
1643
|
318
|
57.9 (49.4, 65.9)
|
75.2 (70.3, 79.5)
|
|
Malaria prevention
|
1644
|
185
|
69.2 (60.5, 76.7)
|
96.9 (95.6, 97.7)
|
|
Action:
| | | | |
|
RDT/BS completed3
|
1556
|
445
|
94.0 (88.8, 96.8)
|
98.1 (95.5, 99.1)
|
|
Prescription made
|
1645
|
1409
|
91.7 (87.8, 94.4)
|
97.9 (92.7, 99.4)
|
|
SP prescribed4
|
1266
|
909
|
83.9 (79.0, 87.7)
|
70.6 (63.4, 83.3)
|
|
1st dose ingested
|
1068
|
548
|
95.5 (93.0, 97.1)
|
95.0 (92.4, 96.8)
|
|
Take away dose
|
1067
|
737
|
98.3 (97.1, 98.9)
|
88.2 (81.7, 92.6)
|
-
1Observations = the number of participants included in the analysis (i.e. the number of observations carried out); 2Occurrences = the number of times the specified advice/action was observed to have occurred (e.g. in 1027/1229 observed clinical case management cases the participant was provided dosage regimen advice); 3RDT = rapid diagnostic test, BS = bloodslide; 4SP = sulphadoxine-pyrimethamine, SP was the most frequently prescribed antimalarial across the three survey samples and is used here as a measure of how accurately patients/caregivers can recall specific antimalarial medications.
